Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Bauer

Showing results (191-200 of 206) with videos related to

Pageof 21
Sort By:
Clinical Pharmacology and Therapeutics|September 6, 2006
A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's diseaseMartin Bauer, Oliver Langer, Peter Dal-Bianco, et al.
Frontiers in Immunology|October 8, 2025
Antiviral and immunomodulatory effect of zapnometinib in animal models and hospitalized COVID-19 patientsYvonne Füll, Lara M Schüssele, Hazem Hamza, et al.
Brain : a Journal of Neurology|November 29, 2011
Blood-brain barrier P-glycoprotein function in Alzheimer's diseaseDaniëlle M E van Assema, Mark Lubberink, Martin Bauer, et al.
The Lancet. Neurology|June 22, 2013
P-glycoprotein expression and function in patients with temporal lobe epilepsy: a case-control studyMaria Feldmann, Marie-Claude Asselin, Joan Liu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 14, 2026
Continuous infusion [<sup>11</sup>C]-(+)-PHNO PET for measuring dopamine D<sub>2/3</sub> receptor availability and amphetamine effects across the brain: Feasibility and test-retest reliabilityIrena Dajic, Ulrich Sauerzopf, Ana Weidenauer, et al.
Clinical Trials (London, England)|February 26, 2026
Shaping the future of clinical trials through strategic foresightSharon Lee, Jeff McIntyre, Tracey Robertson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 15, 2025
Patients with Allan-Herndon-Dudley Syndrome (MCT8 Deficiency) Display Symptoms of Parkinsonism in Childhood and Respond to Levodopa/Carbidopa TreatmentNina-Maria Wilpert, Angela L Hewitt, Roser Pons, et al.
Translational Psychiatry|February 19, 2020
On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D<sub>2/3</sub> receptor agonist radioligand studyAna Weidenauer, Martin Bauer, Ulrich Sauerzopf, et al.
Environmental Pollution (Barking, Essex : 1987)|November 7, 2022
Aerosol emissions from a marine diesel engine running on different fuels and effects of exhaust gas cleaning measuresSeongho Jeong, Jan Bendl, Mohammad Saraji-Bozorgzad, et al.
European Heart Journal|August 11, 2012
Remote ischaemic preconditioning for heart surgery. The study design for a multi-center randomized double-blinded controlled clinical trial--the RIPHeart-StudyPatrick Meybohm, Kai Zacharowski, Jochen Cremer, et al.
Pageof 21

Showing results (191-200 of 206) with videos related to

Sort By:
Pageof 21
Clinical Pharmacology and Therapeutics|September 6, 2006
A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's diseaseMartin Bauer, Oliver Langer, Peter Dal-Bianco, et al.
Frontiers in Immunology|October 8, 2025
Antiviral and immunomodulatory effect of zapnometinib in animal models and hospitalized COVID-19 patientsYvonne Füll, Lara M Schüssele, Hazem Hamza, et al.
Brain : a Journal of Neurology|November 29, 2011
Blood-brain barrier P-glycoprotein function in Alzheimer's diseaseDaniëlle M E van Assema, Mark Lubberink, Martin Bauer, et al.
The Lancet. Neurology|June 22, 2013
P-glycoprotein expression and function in patients with temporal lobe epilepsy: a case-control studyMaria Feldmann, Marie-Claude Asselin, Joan Liu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 14, 2026
Continuous infusion [<sup>11</sup>C]-(+)-PHNO PET for measuring dopamine D<sub>2/3</sub> receptor availability and amphetamine effects across the brain: Feasibility and test-retest reliabilityIrena Dajic, Ulrich Sauerzopf, Ana Weidenauer, et al.
Clinical Trials (London, England)|February 26, 2026
Shaping the future of clinical trials through strategic foresightSharon Lee, Jeff McIntyre, Tracey Robertson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 15, 2025
Patients with Allan-Herndon-Dudley Syndrome (MCT8 Deficiency) Display Symptoms of Parkinsonism in Childhood and Respond to Levodopa/Carbidopa TreatmentNina-Maria Wilpert, Angela L Hewitt, Roser Pons, et al.
Translational Psychiatry|February 19, 2020
On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D<sub>2/3</sub> receptor agonist radioligand studyAna Weidenauer, Martin Bauer, Ulrich Sauerzopf, et al.
Environmental Pollution (Barking, Essex : 1987)|November 7, 2022
Aerosol emissions from a marine diesel engine running on different fuels and effects of exhaust gas cleaning measuresSeongho Jeong, Jan Bendl, Mohammad Saraji-Bozorgzad, et al.
European Heart Journal|August 11, 2012
Remote ischaemic preconditioning for heart surgery. The study design for a multi-center randomized double-blinded controlled clinical trial--the RIPHeart-StudyPatrick Meybohm, Kai Zacharowski, Jochen Cremer, et al.
Pageof 21